News and Announcements
Universal Biosensors Investor Newsletter December 2015
- Published December 16, 2015 2:57PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
As we approach Christmas and the holiday season, we look back at what’s been an eventful year for Universal Biosensors. The year is also ending on a high for innovative companies like UBI with the release of the Federal Government’s innovation policy.
- FROM THE CEO’S DESK
- FEDERAL GOVERNMENT INNOVATION POLICY
- Q&A WITH GARRY CHAMBERS, VP OF TECHNOLOGY DEVELOPMENT
- POINT OF CARE MARKET EXPECTED TO GROW STRONGLY
- SPREADING THE UBI WORD
- J&J SYNCS BLOOD GLUCOSE DATA WITH APPLE HEALTH APP
FROM THE CEO’S DESK
Universal Biosensors has had a year of significant progress and development that’s put us in a strong position to grow further in 2016.
Read more.
FEDERAL GOVERNMENT INNOVATION POLICY
The federal government’s focus on innovation is a welcome development that recognises the importance of our high tech sector and the role it will play in Australia’s economic and social future.
Read more.
Q&A WITH GARRY CHAMBERS, VP OF TECHNOLOGY DEVELOPMENT
“…we are taking a powerful, proven, low-cost system and broadening its application to higher value tests over time.”
Read more.
POINT OF CARE MARKET EXPECTED TO GROW STRONGLY
The point-of-care diagnostics market is forecast to grow strongly in the next five years, with research predicting the global sector to reach $US18 billion by 2020.
Read more.
SPREADING THE UBI WORD
UBI CEO Paul Wright has been promoting the company around Australia and the world, presenting in almost every Australian capital city and in the US, Asia and Europe.
J&J SYNCS BLOOD GLUCOSE DATA WITH APPLE HEALTH APP
Johnson & Johnson’s LifeScan has announced data collected on its blood glucose devices can now be synced with Apple’s Health app on iPhones.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
